Hera News & Events

­

The OncoRat®: Hosting valuable tumor xenograft models that are difficult or impossible to study using in vitro or mouse models

One of the most widely used methods of modeling human [...]

Patient derived xenograft studies from wider varieties of patient sub-populations promise improved clinical trial selection and design

Around 85% of preclinical drugs entering clinical trials in oncology [...]

OncoRat® PDX models highlighted in Drug Discovery News (DDN) Special Report on Cancer: Aiming for Avatars

While advances in in-vitro platforms have allowed researchers to better [...]

Hera Biolabs to present at the 2018 AACR Annual Meeting.

Hera Biolabs will be presenting xenograft, PDX, and humanization of [...]

Understanding Transporter-Mediated Drug-Drug Interactions Using Humanized Liver Mice

Pharmaceutical researchers and regulators are increasingly aware of the influence [...]

Using Patient Derived Xenografts to Improve Therapeutic Cancer Treatments

An increased understanding of human tumors has created a solid [...]

Humanized immune-system SRG Rats™ & mice for immuno-oncology

The SRG rat demonstrates robust immune-system humanization with peripheral blood [...]

Humanized Mouse Models Advance Immunotherapeutic Strategies in Treatment of Type 1 Diabetes

A relatively common autoimmune disease, Type 1 Diabetes (T1D) is [...]

Humanized Mouse Models Advance Immunotherapeutic Strategies in Treatment of Type 1 Diabetes

A relatively common autoimmune disease, Type 1 Diabetes (T1D) is [...]

Using Cell Sheet Technique to Study the Development of HCC in Rat Models

As the single most prevalent primary liver cancer and the [...]